These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

967 related items for PubMed ID: 8137257

  • 1. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K, Koike M, Shitara K, Kuwana Y, Kiuragi K, Igarashi S, Hasegawa M, Hanai N.
    Cancer Res; 1994 Mar 15; 54(6):1511-6. PubMed ID: 8137257
    [Abstract] [Full Text] [Related]

  • 2. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N, Leprieur S, Clémenceau B, Supiot S, Sébille-Rivain V, Faivre-Chauvet A, Davodeau F, Paris F, Barbet J, Aubry J, Birklé S.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [Abstract] [Full Text] [Related]

  • 3. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
    Shibaguchi H, Arakawa F, Imakiire T, Kuroki M, Kuroki M.
    Anticancer Res; 2003 Sep 15; 23(6a):4383-8. PubMed ID: 14666725
    [Abstract] [Full Text] [Related]

  • 4. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF, Sutton VR, Li W, Burgess J, McKEnzie IF, Pietersz GA, Trapani JA.
    Cancer Res; 1994 Dec 01; 54(23):6160-6. PubMed ID: 7954462
    [Abstract] [Full Text] [Related]

  • 5. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
    Coney LR, Mezzanzanica D, Sanborn D, Casalini P, Colnaghi MI, Zurawski VR.
    Cancer Res; 1994 May 01; 54(9):2448-55. PubMed ID: 7512887
    [Abstract] [Full Text] [Related]

  • 6. Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo.
    Fukumoto H, Nishio K, Ohta S, Hanai N, Fukuoka K, Ohe Y, Sugihara K, Kodama T, Saijo N.
    Int J Cancer; 1999 Aug 27; 82(5):759-64. PubMed ID: 10417777
    [Abstract] [Full Text] [Related]

  • 7. Reactivity of a mouse/human chimeric anti-GM2 antibody KM966 with brain tumors.
    Dohi T, Nakamura K, Hanai N, Taomoto K, Oshima M.
    Anticancer Res; 1994 Aug 27; 14(6B):2577-81. PubMed ID: 7872684
    [Abstract] [Full Text] [Related]

  • 8. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK, Horton L, Flahart RE, O'Rear L, Crumpacker D, Imbaratto JW, Yannelli JR, Robinson RR, Oldham RK.
    Hum Antibodies Hybridomas; 1990 Aug 27; 1(2):66-76. PubMed ID: 2103354
    [Abstract] [Full Text] [Related]

  • 9. Reversal of adriamycin resistance with chimeric anti-ganglioside GM2 antibody.
    Fukumoto H, Nishio K, Ohta S, Hanai N, Saijo N.
    Int J Cancer; 1996 Sep 04; 67(5):676-80. PubMed ID: 8782657
    [Abstract] [Full Text] [Related]

  • 10. Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody.
    Nakamura K, Hanibuchi M, Yano S, Tanaka Y, Fujino I, Inoue M, Takezawa T, Shitara K, Sone S, Hanai N.
    Cancer Res; 1999 Oct 15; 59(20):5323-30. PubMed ID: 10537316
    [Abstract] [Full Text] [Related]

  • 11. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
    Sahagan BG, Dorai H, Saltzgaber-Muller J, Toneguzzo F, Guindon CA, Lilly SP, McDonald KW, Morrissey DV, Stone BA, Davis GL.
    J Immunol; 1986 Aug 01; 137(3):1066-74. PubMed ID: 3088107
    [Abstract] [Full Text] [Related]

  • 12. Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG.
    Shitara K, Fujiwara K, Igarashi S, Ohta S, Furuya A, Nakamura K, Koike M, Hanai N.
    J Immunol Methods; 1994 Feb 28; 169(1):83-92. PubMed ID: 8133075
    [Abstract] [Full Text] [Related]

  • 13. Construction and characterization of a high-affinity chimeric anti-colorectal carcinoma antibody ccM4.
    Xiang J, Moyana T, Kalra J, Hamilton T, Qi Y.
    Mol Biother; 1992 Dec 28; 4(4):174-83. PubMed ID: 1476671
    [Abstract] [Full Text] [Related]

  • 14. Recombinant antibodies against ganglioside expressed on tumor cells.
    Hanai N, Nakamura K, Shitara K.
    Cancer Chemother Pharmacol; 2000 Dec 28; 46 Suppl():S13-7. PubMed ID: 10950141
    [Abstract] [Full Text] [Related]

  • 15. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.
    Hu P, Glasky MS, Yun A, Alauddin MM, Hornick JL, Khawli LA, Epstein AL.
    Hum Antibodies Hybridomas; 1995 Dec 28; 6(2):57-67. PubMed ID: 7492752
    [Abstract] [Full Text] [Related]

  • 16. A humanized monoclonal antibody constructed from intronless expression vectors targets human hepatocellular carcinoma cells.
    Chan KT, Cheng SC, Xie H, Xie Y.
    Biochem Biophys Res Commun; 2001 Jun 01; 284(1):157-67. PubMed ID: 11374885
    [Abstract] [Full Text] [Related]

  • 17. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
    Neumaier M, Shively L, Chen FS, Gaida FJ, Ilgen C, Paxton RJ, Shively JE, Riggs AD.
    Cancer Res; 1990 Apr 01; 50(7):2128-34. PubMed ID: 2107969
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.
    Rose B, Gillespie A, Wunderlich D, Kelley K, Dzuiba J, Shedd D, Cahill K, Zerler B.
    Immunology; 1992 Jul 01; 76(3):452-9. PubMed ID: 1526654
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen.
    Nishimura Y, Yokoyama M, Araki K, Ueda R, Kudo A, Watanabe T.
    Cancer Res; 1987 Feb 15; 47(4):999-1005. PubMed ID: 2948638
    [Abstract] [Full Text] [Related]

  • 20. Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case study.
    López-Requena A, Rodríguez M, de Acosta CM, Moreno E, Puchades Y, González M, Talavera A, Valle A, Hernández T, Vázquez AM, Pérez R.
    Mol Immunol; 2007 Feb 15; 44(5):1015-28. PubMed ID: 16620986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.